The pharmaceuticals, medicinal chemicals, seasonally adjusted index in the Netherlands currently stands at 117.5, marking a decrease of 8.9 (-7.0%) compared to 2023 Q4.
Pharmaceuticals, medicinal chemicals, seasonally adjusted index in the Netherlands
No matching regions
Data availability:
Regions:
82
Date range: 2005 Q1 to 2024 Q1
Points:
5,455
Measure:
Index
Similar regions to the Netherlands
Pharmaceuticals, medicinal chemicals
More indicators for the Netherlands
Netherlands Pharmaceuticals, medicinal chemicals between 2005 Q1 and 2024 Q1
| Period | Pharmaceuticals, medicinal chemicals | Change |
|---|---|---|
| 2024 Q1 | 117.5 | -8.9 |
| 2023 Q4 | 126.4 | +3.5 |
| 2023 Q3 | 122.9 | 0.0 |
| 2023 Q2 | 122.9 | +0.3 |
| 2023 Q1 | 122.6 | -22.8 |
| 2022 Q4 | 145.4 | +6.7 |
| 2022 Q3 | 138.7 | +13.6 |
| 2022 Q2 | 125.1 | +6.6 |
| 2022 Q1 | 118.5 | -11.2 |
| 2021 Q4 | 129.7 | +6.1 |
| 2021 Q3 | 123.6 | +10.3 |
| 2021 Q2 | 113.3 | +12.1 |
| 2021 Q1 | 101.2 | -15.1 |
| 2020 Q4 | 116.3 | +14.5 |
| 2020 Q3 | 101.8 | -6.6 |
| 2020 Q2 | 108.4 | +0.4 |
| 2020 Q1 | 108.0 | -7.6 |
| 2019 Q4 | 115.6 | +7.4 |
| 2019 Q3 | 108.2 | +6.1 |
| 2019 Q2 | 102.1 | +3.9 |
| 2019 Q1 | 98.2 | +1.2 |
| 2018 Q4 | 97.0 | +2.0 |
| 2018 Q3 | 95.0 | -7.5 |
| 2018 Q2 | 102.5 | +1.3 |
| 2018 Q1 | 101.2 | -4.2 |
| 2017 Q4 | 105.4 | +9.7 |
| 2017 Q3 | 95.7 | -3.9 |
| 2017 Q2 | 99.6 | -1.7 |
| 2017 Q1 | 101.3 | +7.4 |
| 2016 Q4 | 93.9 | -5.6 |
| 2016 Q3 | 99.5 | -5.8 |
| 2016 Q2 | 105.3 | +9.8 |
| 2016 Q1 | 95.5 | -8.1 |
| 2015 Q4 | 103.6 | +3.4 |
| 2015 Q3 | 100.2 | -1.8 |
| 2015 Q2 | 102.0 | +7.7 |
| 2015 Q1 | 94.3 | -2.6 |
| 2014 Q4 | 96.9 | +2.2 |
| 2014 Q3 | 94.7 | +2.0 |
| 2014 Q2 | 92.7 | -3.6 |
| 2014 Q1 | 96.3 | +11.1 |
| 2013 Q4 | 85.2 | -7.0 |
| 2013 Q3 | 92.2 | +6.5 |
| 2013 Q2 | 85.7 | -4.7 |
| 2013 Q1 | 90.4 | -0.2 |
| 2012 Q4 | 90.6 | -1.2 |
| 2012 Q3 | 91.8 | +10.3 |
| 2012 Q2 | 81.5 | -2.7 |
| 2012 Q1 | 84.2 | +5.1 |
| 2011 Q4 | 79.1 | -7.1 |
| 2011 Q3 | 86.2 | +4.4 |
| 2011 Q2 | 81.8 | -4.5 |
| 2011 Q1 | 86.3 | +4.2 |
| 2010 Q4 | 82.1 | +6.4 |
| 2010 Q3 | 75.7 | -3.4 |
| 2010 Q2 | 79.1 | -0.2 |
| 2010 Q1 | 79.3 | -1.6 |
| 2009 Q4 | 80.9 | +1.1 |
| 2009 Q3 | 79.8 | +0.6 |
| 2009 Q2 | 79.2 | +4.9 |
| 2009 Q1 | 74.3 | +5.4 |
| 2008 Q4 | 68.9 | -1.4 |
| 2008 Q3 | 70.3 | -3.7 |
| 2008 Q2 | 74.0 | +0.6 |
| 2008 Q1 | 73.4 | -9.2 |
| 2007 Q4 | 82.6 | +2.1 |
| 2007 Q3 | 80.5 | +0.3 |
| 2007 Q2 | 80.2 | -2.4 |
| 2007 Q1 | 82.6 | +14.4 |
| 2006 Q4 | 68.2 | +0.6 |
| 2006 Q3 | 67.6 | -6.1 |
| 2006 Q2 | 73.7 | -1.0 |
| 2006 Q1 | 74.7 | +5.0 |
| 2005 Q4 | 69.7 | +2.2 |
| 2005 Q3 | 67.5 | +6.0 |
| 2005 Q2 | 61.5 | -6.3 |
| 2005 Q1 | 67.8 |